The University of Southampton
University of Southampton Institutional Repository

A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma

Pellatt, J., Sweetenham, J., Pickering, R.M., Brown, L. and Wilkins, B. (2002) A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma Annals of Hematology, 81, (5), pp. 267-272. (doi:10.1007/s00277-002-0450-y).

Record type: Article

Abstract

We conducted a retrospective study of treatment outcomes and survival in 120 consecutive, unselected patients with peripheral T-cell non-Hodgkin's lymphoma, presenting at a single centre over a 20-year period. Cases met the criteria of the Revised European-American Lymphoma (REAL) Classification and patients with peripheral T-cell lymphoma of the following subtypes were included: anaplastic large T-cell lymphoma (ALCL), angioimmunoblastic T-cell lymphoma (AILD), peripheral T-cell lymphoma unspecified (PTCLu), and intestinal T-cell lymphoma (ITCL). The study population consisted of 120 patients with a presenting diagnosis of peripheral T-cell lymphoma. Cases that had been previously confirmed as T-cell lymphoma at formal pathology review were identified from the lymphoma database of this institution. Staging investigations, treatment type and outcomes were taken from patient records. For each subtype, clinical characteristics, response to initial treatment, duration of response and any subsequent relapse were recorded. Overall, relapse, and progression-free survival figures were calculated. The ALCL group had the best response rate to first line treatment 19 of 22 (86%) while the AILD group had the lowest response 12 of 29 (41%). Relapse rates were PTCLu 13 of 35 (37%), ITCL 10 of 34 (29%), ALCL 6 of 22 (27%) and AILD 7 of 29 (24%). In terms of median overall survival, a significantly superior survival was demonstrated for the ALCL group (7.05 years) compared to the remaining three groups. The ALCL group had the lowest risk of death while the ITCL group had the highest risk (hazard ratio: 2.82). Five-year survival rates were estimated to be ALCL 60%, PTCLu 40%, AILD 30% and ITCL 25%. This single-centre study demonstrated different outcomes for each group with significant differences in overall survival rates. These findings support the clinical utility of the REAL lymphoma classification in respect to the PTCL subgroups included in this study.

Full text not available from this repository.

More information

Published date: 2002
Keywords: outcomes, peripheral t-cell nhl, real/who classification, survival

Identifiers

Local EPrints ID: 24465
URI: http://eprints.soton.ac.uk/id/eprint/24465
PURE UUID: 94de06d9-3b22-44f3-8655-99ce06fe485b

Catalogue record

Date deposited: 31 Mar 2006
Last modified: 17 Jul 2017 16:13

Export record

Altmetrics

Contributors

Author: J. Pellatt
Author: J. Sweetenham
Author: R.M. Pickering
Author: L. Brown
Author: B. Wilkins

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×